首页> Exploration of drug science> Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).

导出 LinkOut

翻译打印收藏纠错

第一作者： Hassan,Aliashrafzadeh

第一单位： Department of Neurology, University of California, Davis, CA 95616, USA.

作者： Hassan,Aliashrafzadeh ^[1] ; Dewey,Liu ^[1] ; Samantha,De Alba ^[1] ; Imad,Akbar ^[2] ; Austin,Lui ^[1] ; Jordan,Vanleuven ^[1] ; Ryan,Martin ^[3] ; Zhang,Wang ^[4] ; Da Zhi,Liu ^[5]

作者单位： Department of Neurology, University of California, Davis, CA 95616, USA. ^[1] Ayub Medical College, Abbottabad 22020, Pakistan. ^[2] Department of Neurology, University of California, Davis, CA 95616, USA.;Department of Neurological Surgery, University of California, Davis, CA 95616, USA. ^[3] Institute for Psychedelics and Neurotherapeutics, University of California, Davis, CA 95616, USA.;Department of Chemistry, University of California, Davis, CA 95616, USA. ^[4] Department of Neurology, University of California, Davis, CA 95616, USA.;Mirnova Therapeutics, Inc., Davis, CA 95618, USA. ^[5]

关键词 Kinase inhibitors aberrant cell cycle clinical trials neurological disorders preclinical experiments

DOI 10.37349/eds.2025.1008116

PMID 40708570

发布时间 2025-07-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Exploration of drug science

2025年3卷

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Exploration of drug science

2025年3卷

检索历史清除

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).

Exploration of drug science

相似文献

同项目论文

Exploration of drug science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).

Exploration of drug science

相似文献

同项目论文

Exploration of drug science

相关期刊

检索历史清除